Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ma, Yuk Ting"'
Autor:
Bridgewater J; UCL Cancer Institute, London, United Kingdom., Fletcher P; Cancer Clinical Trials Unit, Birmingham, United Kingdom., Palmer DH; Molecular and Clinical Cancer Medicine, Liverpool, United Kingdom., Malik HZ; University Hospital Aintree, Liverpool, United Kingdom., Prasad R; Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom., Mirza D; Birmingham Woman's and Children's NHS Trust, Birmingham, United Kingdom., Anthony A; Leeds Teaching Hospital NHS Trust, Leeds, United Kingdom., Corrie P; Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom., Falk S; University Hospitals Bristol NHS Trust, Bristol, United Kingdom., Finch-Jones M; University Hospitals Bristol NHS Trust, Bristol, United Kingdom., Wasan H; Imperial College Healthcare NHS Trust, London, United Kingdom., Ross P; Guys and St Thomas's NHS Trust, London, United Kingdom., Wall L; Western General Hospital, Edinburgh, United Kingdom., Wadsley J; Weston Park Cancer Centre, Sheffield, United Kingdom., Evans TR; University of Glasgow, Glasgow, United Kingdom., Stocken D; Leeds Institute of Clinical Trials Research, Leeds, United Kingdom., Stubbs C; Cancer Clinical Trials Unit, Birmingham, United Kingdom., Praseedom R; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom., Ma YT; Institute of Immunology and Immunotherapy, Birmingham, United Kingdom., Davidson B; Royal Free Hospital NHS Trust, London, United Kingdom., Neoptolemos J; University of Heidelberg, Heidelberg, Germany., Iveson T; University Hospital Southampton NHS Trust, Southampton, United Kingdom., Cunningham D; Royal Marsden Hospital, London, United Kingdom., Garden OJ; University of Edinburgh, Edinburgh, United Kingdom., Valle JW; University of Manchester, Manchester, United Kingdom., Primrose J; University of Southampton, Southampton, United Kingdom.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Jun 20; Vol. 40 (18), pp. 2048-2057. Date of Electronic Publication: 2022 Mar 22.
Autor:
Lamarca A; Department of Medical Oncology, The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester, Manchester M20 4BX,, UK., Palmer DH; University of Liverpool and Clatterbridge Cancer Centre, Liverpool, UK., Wasan HS; Department of Cancer Medicine, Hammersmith Hospital, Imperial Colllege London, London, UK., Ross PJ; Guy's Cancer, Guy's & St Thomas' NHS Foundation Trust, London, UK., Ma YT; Department of Hepatobiliary Oncology, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Arora A; Department of Medical Oncology, University Hospital of Nottingham NHS Trust, University of Nottingham, Nottingham, UK., Falk S; Bristol Haematology and Oncology Centre, Bristol, UK., Gillmore R; Department of Medical Oncology, Royal Free NHS Foundation Trust, London, UK., Wadsley J; Weston Park Cancer Centre, Sheffield, UK., Patel K; Department of Medical Oncology, Cancer and Haematology Centre, Oxford, UK., Anthoney A; Department of Medical Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Maraveyas A; Department of Medical Oncology, Hull University Teaching Hospitals NHS Trust, Hull, UK., Iveson T; Department of Gastro- Intestinal Oncology, University Hospital Southampton NHS Foundation Trust, Southampton University, Southampton, UK., Waters JS; Kent Oncology Centre, Maidstone, UK., Hobbs C; Department of Clinical Oncology, Great Western Hospital, Swindon, UK., Barber S; Manchester Clinical Trials Unit, University of Manchester, Manchester M20 4BX, UK., Ryder WD; Manchester Clinical Trials Unit, University of Manchester, Manchester M20 4BX, UK., Ramage J; Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK., Davies LM; Manchester Centre for Health Economics, University of Manchester, Manchester M20 4BX, UK., Bridgewater JA; UCL Cancer Institute, University College London, London, UK., Valle JW; Department of Medical Oncology, The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester, Manchester M20 4BX,, UK; Division of Cancer Sciences, University of Manchester, Manchester M20 4BX, UK. Electronic address: juan.valle@manchester.ac.uk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 Jul; Vol. 22 (7), pp. e288-e289.
Autor:
Lamarca A; Department of Medical Oncology, The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester, Manchester, UK., Palmer DH; University of Liverpool and Clatterbridge Cancer Centre, Liverpool, UK., Wasan HS; Department of Cancer Medicine, Hammersmith Hospital, Imperial Colllege London, London, UK., Ross PJ; Guy's Cancer, Guy's & St Thomas' NHS Foundation Trust, London, UK., Ma YT; Department of Hepatobiliary Oncology, University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Arora A; Department of Medical Oncology, University Hospital of Nottingham NHS Trust, University of Nottingham, Nottingham, UK., Falk S; Bristol Haematology and Oncology Centre, Bristol, UK., Gillmore R; Department of Medical Oncology, Royal Free NHS Foundation Trust, London, UK., Wadsley J; Weston Park Cancer Centre, Sheffield, UK., Patel K; Department of Medical Oncology, Cancer and Haematology Centre, Oxford, UK., Anthoney A; Department of Medical Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Maraveyas A; Department of Medical Oncology, Hull University Teaching Hospitals NHS Trust, Hull, UK., Iveson T; Department of Gastro-Intestinal Oncology, University Hospital Southampton NHS Foundation Trust, Southampton University, Southampton, UK., Waters JS; Kent Oncology Centre, Maidstone, UK., Hobbs C; Department of Clinical Oncology, Great Western Hospital, Swindon, UK., Barber S; Manchester Clinical Trials Unit, University of Manchester, Manchester, UK., Ryder WD; Manchester Clinical Trials Unit, University of Manchester, Manchester, UK., Ramage J; Hampshire Hospitals NHS Foundation Trust, Basingstoke, UK., Davies LM; Manchester Centre for Health Economics, University of Manchester, Manchester, UK., Bridgewater JA; UCL Cancer Institute, University College London, London, UK., Valle JW; Department of Medical Oncology, The Christie NHS Foundation Trust/Institute of Cancer Sciences, University of Manchester, Manchester, UK; Division of Cancer Sciences, University of Manchester, Manchester, UK. Electronic address: juan.valle@manchester.ac.uk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2021 May; Vol. 22 (5), pp. 690-701. Date of Electronic Publication: 2021 Mar 30.
Autor:
Primrose JN; Department of Surgery, University of Southampton, Southampton, UK. Electronic address: j.n.primrose@soton.ac.uk., Fox RP; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Palmer DH; University of Liverpool and Clatterbridge Cancer Centre, Liverpool, UK., Malik HZ; Aintree University Hospital, Liverpool, UK., Prasad R; Department of Surgery, University of Leeds, Leeds, UK., Mirza D; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Women's Children's Hospital NHS Foundation Trust, Birmingham, UK., Anthony A; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Corrie P; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Falk S; University of Bristol Hospitals NHS Foundation Trust, Bristol, UK., Finch-Jones M; University of Bristol Hospitals NHS Foundation Trust, Bristol, UK., Wasan H; Imperial Healthcare NHS Trust, London, UK., Ross P; Guys and St Thomas' NHS Foundation Trust, London, UK., Wall L; Lothian University Hospitals NHS Trust, Edinburgh, UK., Wadsley J; Weston Park Hospital, Sheffield, UK., Evans JTR; Department of Oncology, University of Glasgow, Glasgow, UK., Stocken D; Faculty of Medicine and Health, University of Leeds, Leeds, UK., Praseedom R; Addenbrookes Hospital, Cambridge, UK., Ma YT; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK., Davidson B; Department of General Surgery, University College London Hospital, London, UK., Neoptolemos JP; Department of Surgery, University of Heidelberg, Heidelberg, Germany., Iveson T; University Hospitals Southampton, Southampton, UK., Raftery J; Health Economics Analysis Team, University of Southampton, Southampton, UK., Zhu S; Health Economics Analysis Team, University of Southampton, Southampton, UK., Cunningham D; Royal Marsden NHS Trust, London, UK., Garden OJ; Department of Medicine, University of Edinburgh, Edinburgh, UK., Stubbs C; Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, UK., Valle JW; University of Manchester and The Christie NHS Foundation Trust, Manchester, UK., Bridgewater J; UCL Cancer Institute, University College London, London, UK. Electronic address: j.bridgewater@ucl.ac.uk.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 May; Vol. 20 (5), pp. 663-673. Date of Electronic Publication: 2019 Mar 25.
Autor:
Lamarca, Angela, Palmer, Daniel H, Wasan, Harpreet Singh, Ross, Paul J, Ma, Yuk Ting, Arora, Arvind, Falk, Stephen, Gillmore, Roopinder, Wadsley, Jonathan, Patel, Kinnari, Anthoney, Alan, Maraveyas, Anthony, Iveson, Tim, Waters, Justin S, Hobbs, Claire, Barber, Safia, Ryder, W David, Ramage, John, Davies, Linda M, Bridgewater, John A, Valle, Juan W, Grp, Adv Biliary Canc Working
Publikováno v:
Lamarca, A, Palmer, D H, Wasan, H S, Ross, P J, Ma, Y T, Arora, A, Falk, S, Gillmore, R, Wadsley, J, Patel, K, Anthoney, A, Maraveyas, A, Iveson, T, Waters, J S, Hobbs, C, Barber, S, Ryder, W D, Ramage, J, Davies, L M, Bridgewater, J A & Valle, J W 2021, ' Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial ', The Lancet Oncology, vol. 22, no. 5, pp. 690-701 . https://doi.org/10.1016/S1470-2045(21)00027-9
LANCET ONCOLOGY
The Lancet. Oncology
LANCET ONCOLOGY
The Lancet. Oncology
Background\ud \ud Advanced biliary tract cancer has a poor prognosis. Cisplatin and gemcitabine is the standard first-line chemotherapy regimen, but no robust evidence is available for second-line chemotherapy. The aim of this study was to determine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b648e2fdd5880868d388d1b0aac4b6ac
https://linkinghub.elsevier.com/retrieve/pii/S1470204521000279
https://linkinghub.elsevier.com/retrieve/pii/S1470204521000279